Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection
暂无分享,去创建一个
P. Reiss | F. Wit | S. Danner | J. Weel | P. W. Wertheim-van Dillen | N. Pakker | S. Jurriaans | J. Lange | R. van Leeuwen | M. den Brinker | Gerrit Jan Weverling
[1] R. Chaisson,et al. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. , 2000, JAMA.
[2] P. Couzigou,et al. Severe hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations. Aquitaine Cohort, France, 1996-1998. Groupe dEpidémiologie Clinique de Sida en Aquitaine (GECSA). , 1999, AIDS.
[3] M. Velasco,et al. Resolution of chronic hepatitis B after ritonavir treatment in an HIV-infected patient. , 1999, The New England journal of medicine.
[4] P. Reiss,et al. Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons. , 1999, The Journal of infectious diseases.
[5] D. Vlahov,et al. Persistence of viremia and the importance of long‐term follow‐up after acute hepatitis C infection , 1999, Hepatology.
[6] J. Smeitink,et al. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway , 1998, AIDS.
[7] M. Lederman,et al. Recovery of the immune system with antiretroviral therapy: the end of opportunism? , 1998, JAMA.
[8] Ding‐Shinn Chen,et al. Hepatitis B Virus Infection , 2007 .
[9] Edoardo Cervoni,et al. Hepatitis C , 1998, The Lancet.
[10] F. Jeurissen,et al. Is the combination of hepatitis and indinavir potentially dangerous? , 1998, AIDS.
[11] K. Sepkowitz. Effect of HAART on natural history of AIDS-related opportunistic disorders , 1998, The Lancet.
[12] T. Ferraro,et al. Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy. , 1998, AIDS.
[13] J. Gatell,et al. Cytomegalovirus disease in HIV-1-infected patients treated with protease inhibitors. , 1997, AIDS.
[14] D. Cooper,et al. Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor , 1997, The Lancet.
[15] D. Margolis,et al. Severe hepatitis in three AIDS patients treated with indinavir , 1997, The Lancet.
[16] C. Palmer,et al. Emergence of multiple drug-resistant Vibrio cholerae 01 in San Pedro Sula, Honduras , 1997, The Lancet.
[17] H. Chambost,et al. Persistent hepatitis C virus RNA replication in haemophiliacs: role of co‐infection with human immunodeficiency virus , 1995, British journal of haematology.
[18] S. Mallal,et al. Zidovudine‐induced restoration of cell‐mediated immunity to mycobacteria in immunodeficient HIV‐infected patients , 1992, AIDS.
[19] J. Hoofnagle,et al. Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. , 1989, Gastroenterology.
[20] J. Nielsen,et al. The influence of HTLV‐III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers , 1987, Hepatology.
[21] R. Perrillo,et al. Chronic hepatitis B in asymptomatic homosexual men with antibody to the human immunodeficiency virus. , 1986, Annals of internal medicine.
[22] G. Alexander,et al. Relationship Between Expression of Hepatitis B Virus Antigens in Isolated Hepatocytes and Autologous Lymphocyte Cytotoxicity in Patients with Chronic Hepatitis B Virus Infection , 1984, Hepatology.
[23] S. Kakumu,et al. Immunoregulatory T-cell function in acute and chronic liver disease. , 1980, Gastroenterology.